Journal article
36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
Abstract
OBJECTIVE: To determine the longterm safety and efficacy of etidronate therapy in patients in whom corticosteroid induced bone loss has already occurred.
METHODS: We performed a 36 month observational cohort study in which all data were obtained from Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients. The etidronate group consisted of 24 patients who received 400 mg of etidronate disodium for 14 days, followed by 76 days of …
Authors
Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A
Journal
The Journal of Rheumatology, Vol. 26, No. 7, pp. 1545–1549
Publication Date
July 1999
ISSN
0315-162X